Skip to main content
. 2020 Apr;104(4):456–468. doi: 10.1016/j.jhin.2020.01.005

Table IV.

Predictors of 14-day mortality following infection with Klebsiella pneumoniae carbapenemase-producing organisms (KPCO)

Variable Alive at 14 days (N=77)
Died by 14 days (N=20)
Univariate
Multi-variate
N/median %/IQR N/median %/IQR Hazard ratio 95% CI P-value Hazard ratio 95% CI P-value
Age, per year 57 46–65 57 43–66 0.99 (0.96–1.03) 0.64 1.00 (0.97–1.03) 0.84
Female 29 38% 4 20% 0.44 (0.16–1.21) 0.11 0.47 (0.15–1.42) 0.18
Active therapy 67 87% 11 55% 0.23 (0.08–0.62) 0.004 0.32 (0.09–1.10) 0.07
Source control 43 56% 1 5% 0.05 (0.01–0.39) 0.004 0.07 (0.01–0.44) 0.005
Number of previous KPCO infections, per infection 0 0–1 0 0–1 0.99 (0.64–1.53) 0.96 0.76 (0.47–1.24) 0.27
Infection with intrinsically colistin-resistant KPCO 13 17% 9 45% 3.05 (1.39–6.69) 0.005 1.97 (0.83–4.68) 0.12
Charlson score, per point increase 2 0–5 4 0.5–6 1.10 (0.98–1.24) 0.10 0.98 (0.84–1.15) 0.81
Infection focus, intra-abdominal (baseline) #N/A #N/A #N/A #N/A 1.00 1.00
 Bacteraemia 18 23% 2 10% 0.48 (0.10–2.22) 0.35 1.12 (0.30–4.21) 0.86
 Pneumonia 18 23% 7 35% 2.37 (0.49–11.47) 0.29 0.74 (0.23–2.43) 0.62
 Other 1 1% 1 5% 1.54 (0.55–4.34) 0.41 2.12 (0.54–8.30) 0.28

CI, confidence interval.

Note: not including 46 patients with KPCO urinary tract infections, none of whom died within 14 days.